On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.

Slični predmeti

• Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
  od: Roobol, M, i dr.
  Izdano: (2009)
• Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
  od: Blijenberg, BG, i dr.
  Izdano: (2003)
• Prostate cancer screening in Europe and Asia
  od: Kai Zhang, i dr.
  Izdano: (2017-04-01)
• Screening and prostate-cancer mortality in a randomized European study.
  od: Schröder, F, i dr.
  Izdano: (2009)
• Screening for prostate cancer: early detection or overdetection?
  od: Vickers, A, i dr.
  Izdano: (2012)